<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9640">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05693753</url>
  </required_header>
  <id_info>
    <org_study_id>XCMTurin</org_study_id>
    <nct_id>NCT05693753</nct_id>
  </id_info>
  <brief_title>Xenogenic Collagen Matrix for the Treatment of Multiple Gingival Recessions</brief_title>
  <official_title>Coronally Advanced Flap With Xenogenic Collagen Matrix or Autogenous Connective Tissue Graft for the Treatment of Multiple Adjacent Gingival Recessions: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turin, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turin, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to evaluate whether the use of a xenogenic collagen matrix&#xD;
      (XCM) for the treatment of multiple adjacent gingival recessions (MAGRs) with a multiple&#xD;
      coronally advanced flap technique (mCAF) achieves better results than the use of an&#xD;
      autologous connective tissue graft (CTG) in terms of recession reduction (primary outcome)&#xD;
      and other secondary root coverage outcomes (e.g. complete root coverage, mean root coverage).&#xD;
      Moreover, this study aims to compare secondary clinical variables (e.g. keratinized tissue&#xD;
      width (KTW) changes, probing pocket depth (PPD) changes, volumetric gain (VG), etc.), also&#xD;
      with a digital approach, the patient-reported outcome measures (PROMs e.g. pain, swelling,&#xD;
      bleeding). The hypothesis of this study is that at 6 months and 1 year follow-up the mCAF&#xD;
      with XCM is not inferior to CTG in terms of recessions reduction and secondary clinical&#xD;
      variables, and superior regarding to PROMs.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2, 2023</start_date>
  <completion_date type="Anticipated">December 2, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Recession Reduction (RecRed)</measure>
    <time_frame>6 months; 1 year</time_frame>
    <description>Mean changes in mm in recession depth between baseline and 1-year</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete Root Coverage (CRC)</measure>
    <time_frame>6 months; 1 year</time_frame>
    <description>Percentage of sites with complete root coverage after 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Root Coverage (MRC)</measure>
    <time_frame>6 months; 1 year</time_frame>
    <description>Percentage of mean root coverage after 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Keratinised tissue height (KTH) changes</measure>
    <time_frame>6 months; 1 year</time_frame>
    <description>Linear changes in mm from the gingival margin to the mucogingival junction between baseline and 1-year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative morbidity (pain, swelling, discomfort)</measure>
    <time_frame>14 days</time_frame>
    <description>Assessment of patient's pain, swelling and discomfort at 14 days after the procedure using visual analogue scale (VAS) ranging from 0 (no pain, swelling or discomfort) to 10 (maximum pain, swelling or discomfort) with a questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Gingival Recession, Generalized</condition>
  <arm_group>
    <arm_group_label>Xenogenic collagen matrix (XCM)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multiple coronally advanced flap technique (mCAF) with the use of a XCM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Connective tissue graft (CTG)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Multiple coronally advanced flap technique (mCAF) with the use of a CTG</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Use of XCM for the treatment of MAGRs with mCAF technique</intervention_name>
    <description>After local anaesthesia, mCAF technique will be performed. XCM will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction.</description>
    <arm_group_label>Xenogenic collagen matrix (XCM)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Treatment of MAGRs with CTG</intervention_name>
    <description>After local anaesthesia, mCAF technique will be performed. CTG will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction.</description>
    <arm_group_label>Connective tissue graft (CTG)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 18 years old and able to sign informed consent&#xD;
&#xD;
          -  At least 2 adjacent teeth with RT1 and/or RT2 gingival recessions without&#xD;
             interproximal exposure of the CEJ (interdental gingival recession), at least one with&#xD;
             a depth of â‰¥2mm with indication for root coverage treatment&#xD;
&#xD;
          -  A minimum of 4 adjacent teeth (including the ones to be treated) in the region of&#xD;
             interest&#xD;
&#xD;
          -  Available to attend study related procedures (including follow-up visits)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Systemic diseases/medications which could influence the outcome of the therapy (e.g.,&#xD;
             uncontrolled diabetes mellitus);&#xD;
&#xD;
          -  Current smokers (self-reported, any type of smoking), users of chewing tobacco, and&#xD;
             drug/alcohol abusers;&#xD;
&#xD;
          -  Pregnant or nursing women;&#xD;
&#xD;
          -  History of previous periodontal surgery (mucogingival or other) on the teeth to be&#xD;
             included;&#xD;
&#xD;
          -  Furcation involvement in the teeth to be included;&#xD;
&#xD;
          -  Presence of severe tooth malposition, rotation or clinically significant extrusion in&#xD;
             the teeth to be treated;&#xD;
&#xD;
          -  Presence of fixed or removable prosthesis in the area to be treated&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mario Aimetti, MD</last_name>
    <phone>0116331546</phone>
    <email>mario.aimetti@unito.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>CIR Dental School</name>
      <address>
        <city>Turin</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Mario Aimetti, Prof.</last_name>
      <phone>+39116331541</phone>
      <email>mario.aimetti@unito.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 11, 2023</study_first_submitted>
  <study_first_submitted_qc>January 11, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2023</study_first_posted>
  <last_update_submitted>January 11, 2023</last_update_submitted>
  <last_update_submitted_qc>January 11, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingival Recession</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

